We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Home » AstraZeneca Profit Down 5 Percent From Generic Competition in US
AstraZeneca Profit Down 5 Percent From Generic Competition in US
January 27, 2011
Competition from generic drugs in the United States contributed to a 5 percent drop in net profit for AstraZeneca PLC in the fourth quarter, the pharmaceutical firm reported Thursday. StarTribune
